Laddar...
Both Fidaxomicin and Vancomycin Inhibit Outgrowth of Clostridium difficile Spores
Fidaxomicin (FDX) is approved to treat Clostridium difficile-associated diarrhea and is superior to vancomycin in providing a sustained clinical response (cure without recurrence in the subsequent 25 days). The mechanism(s) behind the low recurrence rate of FDX-treated patients could be multifactori...
Sparad:
| Huvudupphovsmän: | , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
American Society for Microbiology
2013
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3535933/ https://ncbi.nlm.nih.gov/pubmed/23147724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01611-12 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|